ProCE Banner Activity

子宫内膜癌分子学重新分类:确定适合接受免疫治疗的患者

Clinical Thought

阅读 Domenica Lorusso 博士有关子宫内膜癌管理的最新临床数据和免疫疗法现状的中文版评论。

This educational activity is intended for clinicians practicing medicine outside of the United States.

Released: March 26, 2021

Expiration: March 25, 2022

No longer available for credit.

Share

Faculty

Domenica Lorusso

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

Supporters

Supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

医学博士和哲学博士 Domenica Lorusso 透露,她已从 Amgen、AstraZeneca、Clovis、GlaxoSmithKline、MSD 和 Pharmamar 收到咨询费;从 MSD 收到非 CME/CE 服务的费用;并从 AstraZeneca、Clovis、GlaxoSmithKline 和 Pharmamar 获得了其他财务或物资支持。